DarioHealth Corp. (DRIO) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

DarioHealth Corp. (DRIO) Healthcare & Pipeline Overview

DarioHealth Corp. is a digital therapeutics company providing chronic condition management solutions, including diabetes, hypertension, weight management, musculoskeletal conditions, and behavioral health. Their integrated platform combines connected devices, data analytics, and personalized coaching across the United States, Canada, Europe, Australia, and New Zealand.

What Is the Investment Thesis for DRIO?

DarioHealth Corp. presents a notable research candidate within the growing digital therapeutics market. The company's integrated platform, addressing multiple chronic conditions, positions it to capitalize on the increasing demand for remote patient monitoring and personalized healthcare solutions. With a market capitalization of $49.5M and a gross margin of 56.6%, DarioHealth demonstrates potential for scalability and profitability. Key growth catalysts include expanding partnerships with employers and health plans, launching new product offerings, and penetrating new geographic markets. However, investors should be aware of potential risks, including competition from established players in the healthcare industry and the need to navigate complex regulatory landscapes. The company's P/E ratio of 6.2 and profit margin of 276.1% suggest strong earnings potential if growth initiatives are executed effectively.

Based on FMP financials and quantitative analysis

DRIO Key Highlights

• Market Cap of $49.5M reflects the company's current valuation in the digital therapeutics market.
• Gross Margin of 56.6% indicates strong profitability in its product and service offerings.
• P/E Ratio of 6.2 suggests potential undervaluation compared to industry peers.
• Profit Margin of 276.1% highlights efficient cost management and revenue generation.
• Beta of 1.28 indicates higher volatility compared to the overall market.

Who Are DRIO's Competitors?

DRIO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are DRIO's Key Strengths?

• Integrated digital therapeutics platform.
• Comprehensive solutions for multiple chronic conditions.
• Strong data analytics capabilities.
• Established partnerships with employers and health plans.

What Are DRIO's Weaknesses?

• Relatively small market capitalization.
• Limited brand recognition compared to larger competitors.
• Dependence on partnerships for market access.
• Potential regulatory hurdles in new markets.

What Could Drive DRIO Stock Higher?

• Expansion of partnerships with major health insurance providers to increase market reach.
• Continued adoption of DarioHealth's platform by employers seeking to reduce healthcare costs.
• Launch of new features and integrations to enhance user experience and engagement.
• Positive clinical trial results demonstrating the effectiveness of DarioHealth's solutions.

What Are the Key Risks for DRIO?

• Financial-distress signal — its Altman Z-Score of -6.18 sits in the distress zone (elevated bankruptcy risk).
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Increased competition from established healthcare companies entering the digital therapeutics market.
• Regulatory changes impacting the reimbursement of digital health solutions.
• Data security breaches compromising patient privacy and trust.
• Economic downturn affecting employer-sponsored wellness programs.

What Are the Growth Opportunities for DRIO?

• Expansion of Enterprise Partnerships: DarioHealth can significantly grow its revenue by expanding partnerships with employers and health plans. These partnerships provide access to a large pool of potential users and offer recurring revenue streams. The market for employer-sponsored wellness programs is estimated to be worth billions of dollars annually, presenting a substantial opportunity for DarioHealth to increase its market share by offering comprehensive chronic condition management solutions to corporate clients.
• New Product Development and Innovation: Investing in research and development to expand its product portfolio and introduce new features can drive growth. The digital therapeutics market is constantly evolving, and companies that can innovate and adapt to changing consumer needs will be best positioned for success. DarioHealth can leverage its data analytics capabilities to identify unmet needs and develop targeted solutions for specific patient populations.
• Geographic Expansion: DarioHealth has the opportunity to expand its geographic footprint beyond its current markets in the United States, Canada, Europe, Australia, and New Zealand. Entering new markets, such as Asia and Latin America, can significantly increase its potential customer base and drive revenue growth. However, it is important to carefully consider the regulatory and cultural differences in each market before entering.
• Strategic Acquisitions and Partnerships: Pursuing strategic acquisitions and partnerships can accelerate growth and expand its capabilities. Acquiring complementary technologies or companies can enhance its product offerings and provide access to new markets. Partnering with established healthcare providers can improve its credibility and facilitate market access.
• Increased Focus on Personalized Medicine: By leveraging data analytics and artificial intelligence, DarioHealth can further personalize its solutions to meet the unique needs of each patient. Personalized medicine is a growing trend in healthcare, and companies that can deliver tailored solutions will have a competitive advantage. DarioHealth can use its data to identify individual risk factors and develop customized treatment plans.

What Opportunities Does DRIO Have?

• Expansion of enterprise partnerships.
• New product development and innovation.
• Geographic expansion into new markets.
• Strategic acquisitions and partnerships.

What Threats Does DRIO Face?

• Competition from established healthcare providers.
• Evolving regulatory landscape.
• Data security and privacy concerns.
• Reimbursement challenges for digital therapeutics.

What Are DRIO's Competitive Advantages?

• Integrated Platform: Combines connected devices, data analytics, and personalized coaching.
• Multi-Condition Approach: Addresses multiple chronic conditions on a single platform.
• Data Analytics Capabilities: Leverages data to personalize treatment plans and improve outcomes.
• Established Partnerships: Collaborates with employers and health plans for market access.

What Does DRIO Do?

DarioHealth Corp., founded in 2011 and headquartered in New York City, operates as a digital therapeutics company focused on providing comprehensive solutions for chronic condition management. Originally named LabStyle Innovations Corp., the company rebranded to DarioHealth Corp. in July 2016 to reflect its expanded focus on digital health solutions. The company's core offering is an integrated platform that combines connected medical devices, data analytics, and personalized coaching to empower individuals to manage their health proactively. DarioHealth's solutions address a range of chronic conditions, including diabetes, hypertension, weight management, musculoskeletal (MSK) conditions, and behavioral health. Their product suite includes smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, and biofeedback sensor devices. These devices integrate with the DarioEngage platform, a proprietary care management system that provides users with real-time data insights, personalized feedback, and access to live coaching. DarioHealth operates in the United States, Canada, the European Union, Australia, and New Zealand, targeting both individual consumers and enterprise clients, such as employers and health plans. The company's business model centers on providing comprehensive, data-driven solutions that improve health outcomes and reduce healthcare costs.

What Products and Services Does DRIO Offer?

• Provides digital therapeutic solutions for chronic condition management.
• Offers a platform integrating connected devices, data analytics, and personalized coaching.
• Addresses metabolic health needs, including diabetes, hypertension, and weight management.
• Manages musculoskeletal conditions through its Dario Musculoskeletal program.
• Offers behavioral health solutions for mental wellness.
• Provides smart glucose meters and blood pressure cuffs for remote monitoring.
• Offers diabetes management programs with lifestyle changes and live coaching.

How Does DRIO Make Money?

• Generates revenue through the sale of connected medical devices.
• Offers subscription-based access to its DarioEngage platform.
• Partners with employers and health plans to provide chronic condition management solutions.
• Provides device-specific disposables like test strips and lancets.

What Industry Does DRIO Operate In?

DarioHealth Corp. operates within the rapidly expanding digital therapeutics market, driven by increasing prevalence of chronic diseases and the growing adoption of remote patient monitoring technologies. DarioHealth competes with a range of companies, from established healthcare providers to emerging digital health startups. Key competitive factors include product innovation, clinical validation, and market access. DarioHealth's integrated platform and multi-condition approach differentiate it from competitors focused on single disease management.

Who Are DRIO's Key Customers?

• Individual consumers seeking to manage chronic conditions.
• Employers offering wellness programs to their employees.
• Health plans seeking to improve patient outcomes and reduce healthcare costs.
• Healthcare providers integrating digital therapeutics into their practice.

DRIO Valuation & Market Position

With a $49.5M market cap, DarioHealth Corp. sits in the micro-cap segment of the market. Relative to its peer group, DRIO's quantitative score of 31/100 is below the peer average of 60/100.

FY2026 estForward Outlook

Wall Street analysts project DarioHealth Corp. revenue of about $26.2M for fiscal 2026, with EPS near $-3.71. The estimate reflects 3 contributing analysts.

F-Score 3/9Financial Health

DarioHealth Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.18 places it in the distress zone, a signal of elevated financial risk.

ROE 93%Key Financial Metrics

Return on equity for DarioHealth Corp. stands at 93.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 60.7%, showing how much profit it generates from its asset base. DRIO trades at a trailing price-to-earnings ratio of 6.22, below the Healthcare sector average of ~23x. Its free cash flow yield is -52.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.04 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 19.1%, the inverse of the P/E and a quick read on earnings relative to price.

DRIO Financials

DRIO Latest News

DRIO Analyst Consensus

DRIO MoonshotScore

DRIO Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources